The global human immunoglobulin market is anticipated to grow at a considerable CAGR of 6.4% during the forecast period (2022-2028). Increasing research & development initiatives in the discovery of innovative medications for illness management are projected to boost the market growth. To gain on the opportunity key players operating in the global human immunoglobulin market had been adopting strategies to achieve major market share. For instance, in January 2019, the US Food and Drug Administration granted Kedrion Biopharma GmbH, the license to conduct clinical research to assess the efficacy and safety of a 10% intravenous immunoglobulin in the treatment of people with primary immunodeficiency diseases (PID).
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/human-immunoglobulin-market
Additionally, after the COVID-19 Pandemic, the need for plasma increased rapidly, hence ensuring plasma supply and enhanced fractionation techniques to maximize yield from each liter of plasma is also supporting the growth of the market. WHO is trying to establish a national blood system across the globe capable of providing sufficient and timely supplies of safe blood and blood products to meet the transfusion needs of all patients, with well-organized and coordinated blood transfusion services, effective evidence-based and ethical national blood policies, and legislation and regulation. For instance, in 30 June 2021, the Czech Republic’s national public health authority, SUKL, had granted Biotest an operating license for its eighth plasma collection center.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
o By Type
o By Disease Indication
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- including Baxter International Inc., CSL Ltd., Grifols S.A., Kedrion Biopharma Inc., Octapharma AG, and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Human Immunoglobulin Market Report Segment
By Type
- Liquid
- Powder
By Disease Indication
- Infectious hepatitis
- Measles
A full report of Human Immunoglobulin Market is available at: https://www.omrglobal.com/industry-reports/human-immunoglobulin-market
Human Immunoglobulin Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Biotest AG
- Bio Products laboratory Ltd.
- CBPO
- CNBG Co. Ltd.
- GC Pharma
- Hualan Bio
- LFB Group Co. Ltd.
- Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.
- Shanghai RAAS
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
